Innovation Pharmaceuticals Inc. (IPIX)
Develops experimental drugs to treat inflammatory diseases, cancer, and infections.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+800.0%
The outlook
IPIX trades at $0.0027, sitting well above both its 50- and 200-day moving averages, though it remains near the bottom of its 52-week range. Analyst coverage appears thin, and the overall sentiment is neutral. The stock shows resilience relative to recent lows but limited upside room within its annual trading band.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$1.4M
52-wk high
$0.05
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—